USD24.60
Poster Session I - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, ‘OMICS AND BIOMARKERS P463 - ESOC25-2074 PLASMA PTAU217 AS A BIOMARKER FOR POST-STROKE COGNITIVE IMPAIRMENT PREDICTION: A NESTED CASE-CONTROL STUDY Elena Escriche 1 , María Molina 1 , Mónica MacÍas 2 , Inhar Esnaola 1 , Adrián Jiménez 1 , Miren Roldan 2 , Amaya Urdánoz-Casado 2,3 , Nuria Sobrino 4 , Celia Fernández 4 , Idoia Rubio 1 , Roberto Muñoz 1,3 , Maria Herrera Isasi 1,3 , Maite Mendioroz 1,2,3 1 Neurology Department, University Hospital of Navarra, Pamplona, Spain, 2 Neuroepigenetics Unit, Navarrabiomed-UPNA, Pamplona, Spain, 3 Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS)- ISC III, Madrid, Spain, 4 Radiology Department, University Hospital of Navarra, Pamplona, Spain Background and Aims: Post-stroke cognitive impairment (PSCI) represents a significant complication affecting stroke survivors >20% discount Size:100 Tablet Menopause Beauty & Wellbeing Bundle – CORREXIKO UK https://biolabshop.pl/297-medium_default/ipamorelin-2-mg.jpg
USD24.60
USD29.51
USD24.61
USD23.83
USD20.91
USD23.09
USD22.94
USD23.35